Related Experiment Video
Updated: Oct 3, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Dominant-negative TAK1 induces c-Myc and G(0) exit in liver
C A Bradham1, E Hatano, D A Brenner
1Department of Medicine, University of North Carolina at Chapel Hill, 27707, USA.
Abstract:
Transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1), a serine/threonine kinase, is reported to function in the signaling pathways of TGF-beta, interleukin 1, and ceramide. However, the physiological role of TAK1 in vivo is largely unknown. To assess the function of TAK1 in vivo, dominant-negative TAK1 (dnTAK1) was expressed in the rat liver by adenoviral gene transfer. dnTAK1 expression abrogated c-Jun NH(2)-terminal kinase and c-Jun but not nuclear factor (NF)-kappaB or SMAD activation after partial hepatectomy (PH). Expression of dnTAK1 or TAM-67, a dominant-negative c-Jun, induced G(0) exit in quiescent liver and accelerated cell cycle progression after PH. Finally, dnTAK1 and TAM-67 induced c-myc expression in the liver before and after PH, suggesting that G(0) exit induced by dnTAK1 and TAM-67 is mediated by c-myc induction.
Insights
Transforming growth factor-beta-activated kinase 1 (TAK1) is crucial for liver cell cycle regulation. Inhibiting TAK1 in rats promoted cell cycle entry and progression, mediated by c-myc induction.
Area of Science:
- Molecular Biology
- Cell Biology
- Hepatology
Background:
- Transforming growth factor-beta (TGF-beta)-activated kinase 1 (TAK1) is a kinase involved in TGF-beta, interleukin-1, and ceramide signaling pathways.
- The precise physiological role of TAK1 in vivo remains largely uncharacterized.
Purpose of the Study:
- To investigate the in vivo function of TAK1 in liver physiology.
- To elucidate TAK1's role in cell cycle regulation and signaling pathways within the liver.
Main Methods:
- Adenoviral gene transfer was used to express dominant-negative TAK1 (dnTAK1) in rat liver.
- Partial hepatectomy (PH) was performed to stimulate liver regeneration.
- Activation of signaling pathways including c-Jun NH(2)-terminal kinase, c-Jun, nuclear factor (NF)-kappaB, and SMAD was assessed.
- Expression of c-myc was analyzed before and after PH.
Main Results:
- dnTAK1 expression inhibited c-Jun NH(2)-terminal kinase and c-Jun activation post-PH, but not NF-kappaB or SMAD activation.
- Expression of dnTAK1 or TAM-67 (a dominant-negative c-Jun) induced G(0) exit in quiescent liver cells.
- dnTAK1 and TAM-67 accelerated cell cycle progression following PH.
- Both dnTAK1 and TAM-67 induced c-myc expression in the liver, both before and after PH.
Conclusions:
- TAK1 plays a significant role in regulating liver cell cycle progression.
- The G(0) exit induced by TAK1 inhibition is mediated through the induction of c-myc.
- TAK1 is a key regulator of liver regeneration and cell proliferation via c-myc.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic cells are...
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

